Ralph Liporace

Safety, tolerability, and efficacy of KP-1461 as monotherapy for 124 days in antiretroviral-experienced, HIV type 1-infected subjects.

R. Redfield, C. Hicks, P. Clay, 2012, AIDS research and human retroviruses.

Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals

C. Kovacs, D. Cooper, R. Steigbigel, 2006, Journal of acquired immune deficiency syndromes.

Induction of Adrenal Suppression by Megestrol Acetate in Patients with AIDS

M. Leinung, Cynthia Miller, Ralph Liporace, 1995, Annals of Internal Medicine.

Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.

R. Redfield, C. Fichtenbaum, M. Saag, 2008, The Journal of infectious diseases.